...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith - Exempt Distribution
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Another one dated: 2022-01-27

Promissory Note: $504,240.00 CAN (no other details provided when the note comes due and at what rate of interest)

Warrants: 200,000 @ $0.95 CAN / Expiry date, 2027-01-27

 

Koo

ps: Please excuse the misspelled ZENITH in the previous post heading. 

 

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply